Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xanthine Oxidase Inhibition in Renal Transplant Recipients

NCT01332799 is registered in ClinicalTrials.gov with Roberto S Kalil as lead sponsor.

NCT NCT01332799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01332799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xanthine Oxidase Inhibition in Renal Transplant Recipients
Lead sponsor
Roberto S Kalil
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2011
Completion date
August 10, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complications of renal transplant